Top Markets
Coin of the day
Apontis Pharma AG Apontis Pharma AG

Apontis Pharma AG

APPH
Rang in Aktien #21489
Operating within Germany, Apontis Pharma AG specializes in the marketing and... Operating within Germany, Apontis Pharma AG specializes in the marketing and distribution of pharmaceutical products, with a particular emphasis on internal medicine. The company is actively involved in the development, promotion, and commercialization of a diverse portfolio, which includes combination single-pill therapies and other medications. Key therapeutic areas of focus encompass cardiovascular diseases, such as high blood pressure (hypertension), elevated cholesterol (hyperlipidemia), and strategies for secondary prevention, in addition to respiratory ailments and diabetes. Established in 1946, Apontis Pharma AG maintains its corporate headquarters in Monheim am Rhein, Germany.
Aktienkurs
$12.75
Zuletzt synchronisiert: 2025-11-17
Marktkapitalisierung
$106.20M
Veränderung (1 Tag)
-2.29%
Veränderung (1 Jahr)
0.24%
Land
DE
Handel Apontis Pharma AG (APPH)

Kategorie

Dividendenrendite-Verlauf für Apontis Pharma AG (APPH)
Dividendenrendite (TTM) von Apontis Pharma AG (Aktienkürzel: APPH) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Apontis Pharma AG (APPH) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber